BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30460706)

  • 1. Study of the cytotoxic and genotoxic potential of the carbonyl ruthenium(II) compound, ct-[RuCl(CO)(dppb)(bipy)]PF
    Carnizello AP; Alves JM; Pereira DE; Campos JCL; Barbosa MIF; Batista AA; Tavares DC
    J Appl Toxicol; 2019 Apr; 39(4):630-638. PubMed ID: 30460706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo antitumor activity of a novel carbonyl ruthenium compound, the ct-[RuCl(CO)(dppb)(bipy)]PF-6[dppb=1,4-bis(diphenylphosphine)butane and bipy=2,2'-bipyridine].
    Carnizello AP; Barbosa MI; Martins M; Ferreira NH; Oliveira PF; Magalhães GM; Batista AA; Tavares DC
    J Inorg Biochem; 2016 Nov; 164():42-48. PubMed ID: 27613330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cis-[RuCl(BzCN)(N-N)(P-P)]PF6 complexes: Synthesis and in vitro antitumor activity: (BzCN=benzonitrile; N-N=2,2'-bipyridine; 1,10-phenanthroline; P-P=1,4-bis(diphenylphosphino) butane, 1,2-bis(diphenylphosphino)ethane, or 1,1'-(diphenylphosphino)ferrocene).
    Pereira Fde C; Lima BA; de Lima AP; Pires WC; Monteiro T; Magalhães LF; Costa W; Graminha AE; Batista AA; Ellena J; Siveira-Lacerda Ede P
    J Inorg Biochem; 2015 Aug; 149():91-101. PubMed ID: 25873134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-mutagenic Ru(ii) complexes: cytotoxicity, topoisomerase IB inhibition, DNA and HSA binding.
    da Silva MM; de Camargo MS; Correa RS; Castelli S; De Grandis RA; Takarada JE; Varanda EA; Castellano EE; Deflon VM; Cominetti MR; Desideri A; Batista AA
    Dalton Trans; 2019 Oct; 48(39):14885-14897. PubMed ID: 31555783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ru(II)/clotrimazole/diphenylphosphine/bipyridine complexes: Interaction with DNA, BSA and biological potential against tumor cell lines and Mycobacterium tuberculosis.
    Colina-Vegas L; Dutra JL; Villarreal W; de A Neto JH; Cominetti MR; Pavan F; Navarro M; Batista AA
    J Inorg Biochem; 2016 Sep; 162():135-145. PubMed ID: 27383651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization and in vitro cytotoxicity of ruthenium(II) metronidazole complexes: Cell cycle arrest at G1/S transition and apoptosis induction in MCF-7 cells.
    Candido CC; Silva HVR; Zavan B; Ionta M; Barbosa MIF; Doriguetto AC
    J Inorg Biochem; 2022 Dec; 237():112022. PubMed ID: 36244314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).
    Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA
    Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
    Popolin CP; Reis JPB; Becceneri AB; Graminha AE; Almeida MAP; Corrêa RS; Colina-Vegas LA; Ellena J; Batista AA; Cominetti MR
    PLoS One; 2017; 12(9):e0183275. PubMed ID: 28898246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiparasitic activities of novel ruthenium/lapachol complexes.
    Barbosa MI; Corrêa RS; de Oliveira KM; Rodrigues C; Ellena J; Nascimento OR; Rocha VP; Nonato FR; Macedo TS; Barbosa-Filho JM; Soares MB; Batista AA
    J Inorg Biochem; 2014 Jul; 136():33-9. PubMed ID: 24727183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro-apoptotic activity of ruthenium 1-methylimidazole complex on non-small cell lung cancer.
    Dias JSM; Silva HVR; Ferreira-Silva GÁ; Ionta M; Corrêa CC; Almeida F; Colina-Vegas L; Barbosa MIF; Doriguetto AC
    J Inorg Biochem; 2018 Oct; 187():1-13. PubMed ID: 30015231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ruthenium complexes show promise when submitted to toxicological safety tests using alternative methodologies.
    Teixeira TM; Arraes IG; Abreu DC; Oliveira KM; Correa RS; Batista AA; Braunbeck T; de Paula Silveira Lacerda E
    Eur J Med Chem; 2021 Apr; 216():113262. PubMed ID: 33711764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization, X-ray structure and in vitro antimycobacterial and antitumoral activities of Ru(II) phosphine/diimine complexes containing the "SpymMe2" ligand, SpymMe2=4,6-dimethyl-2-mercaptopyrimidine.
    do Nascimento FB; Von Poelhsitz G; Pavan FR; Sato DN; Leite CQ; Selistre-de-Araújo HS; Ellena J; Castellano EE; Deflon VM; Batista AA
    J Inorg Biochem; 2008 Sep; 102(9):1783-9. PubMed ID: 18614238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic carboxylate and thioacetate ruthenium(ii) complexes: synthesis and cytotoxic activity against anaplastic thyroid cancer cells.
    Lovison D; Allegri L; Baldan F; Ballico M; Damante G; Jandl C; Baratta W
    Dalton Trans; 2020 Jun; 49(24):8375-8388. PubMed ID: 32520028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cis-[RuCl(BzCN)(bipy)(dppe)]PF6 induces anti-angiogenesis and apoptosis by a mechanism of caspase-dependent involving DNA damage, PARP activation, and Tp53 induction in Ehrlich tumor cells.
    Magalhães LF; Mello-Andrade F; Pires WC; Silva HD; da Silva PFF; Macedo LM; Henrique de Castro C; Carneiro CC; Cardoso CG; de Melo Reis PR; Camargo de Oliveira L; Caetano RR; Batista AA; Silveira-Lacerda EP
    Chem Biol Interact; 2017 Dec; 278():101-113. PubMed ID: 28935426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of in vitro absorption in Caco-2 monolayers of anticancer Ru(II)-based complexes acting as dual human topoisomerase and PARP inhibitors.
    de Camargo MS; De Grandis RA; da Silva MM; da Silva PB; Santoni MM; Eismann CE; Menegário AA; Cominetti MR; Zanelli CF; Pavan FR; Batista AA
    Biometals; 2019 Feb; 32(1):89-100. PubMed ID: 30506342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ruthenium(II)/Benzonitrile Complex Induces Cytotoxic Effect in Sarcoma-180 Cells by Caspase-Mediated and Tp53/p21-Mediated Apoptosis, with Moderate Brine Shrimp Toxicity.
    Faria RS; Silva HD; Mello-Andrade F; Pires WC; de Castro Pereira F; de Lima AP; de Fátima Oliveira Santos S; Teixeira TM; da Silva PFF; Naves PLF; Batista AA; da Silva Oliveira RJ; Reis RM; de Paula Silveira-Lacerda E
    Biol Trace Elem Res; 2020 Dec; 198(2):669-680. PubMed ID: 32266641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heteroleptic mononuclear compounds of ruthenium(ii): synthesis, structural analyses, in vitro antitumor activity and in vivo toxicity on zebrafish embryos.
    Lenis-Rojas OA; Fernandes AR; Roma-Rodrigues C; Baptista PV; Marques F; Pérez-Fernández D; Guerra-Varela J; Sánchez L; Vázquez-García D; Torres ML; Fernández A; Fernández JJ
    Dalton Trans; 2016 Dec; 45(47):19127-19140. PubMed ID: 27868117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the biological potential of ruthenium(II) complexes with cinnamic acid.
    Graminha AE; Honorato J; Dulcey LL; Godoy LR; Barbosa MF; Cominetti MR; Menezes AC; Batista AA
    J Inorg Biochem; 2020 May; 206():111021. PubMed ID: 32163810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ruthenium(II) phosphine/diimine/picolinate complexes: inorganic compounds as agents against tuberculosis.
    Pavan FR; Poelhsitz GV; Barbosa MI; Leite SR; Batista AA; Ellena J; Sato LS; Franzblau SG; Moreno V; Gambino D; Leite CQ
    Eur J Med Chem; 2011 Oct; 46(10):5099-107. PubMed ID: 21875763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute toxic effects of ruthenium (II)/amino acid/diphosphine complexes on Swiss mice and zebrafish embryos.
    Mello-Andrade F; Cardoso CG; Silva CRE; Chen-Chen L; Melo-Reis PR; Lima AP; Oliveira R; Ferraz IBM; Grisolia CK; Almeida MAP; Batista AA; Silveira-Lacerda EP
    Biomed Pharmacother; 2018 Nov; 107():1082-1092. PubMed ID: 30257320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.